IN THE NEWS: Media coverage and video of Sheller, P.C. Risperdal lawsuit settlements; Sheller represents hundreds of boys in J&J Risperdal breast growth litigation
2013-05-09 -J&J settles a total of six lawsuits with Sheller, P.C. clients; hundreds more represented
News Coverage:
J&J Balks on Deal to Settle U.S. Probe, The Wall Street Journal, May 9, 2013 (quotes Attorney Stephen Sheller on lawsuits involving boys and young men who developed gynecomastia while taking Risperdal)
Six Risperdal Suits to See Appeal Over Marketer's Dismissal, Law360/LexisNexis, November 16, 2012 (requires subscription, see text here)
Johnson & Johnson settles six Risperdal boy breas tlawsuits, hundreds of cases pending, CBS Moneywatch (PR Web distribution), October 10, 2012
Johnson & Johnson settles five Risperdal suits, The Philadelphia Inquirer, October 5, 2012
First Risperdal Trial Ends with Settlement, six cases total have settled in the litigation, The Legal Intelligencer, October 5, 2012 (PDF of newspaper)
J&J resolves 5 Risperdal off-label cases, Law360/LexisNexis, October 4, 2012
Johnson & Johnson agrees to settle five Risperdal suits, Bloomberg Business Week, October 4, 2012
Former FDA Commish slams J&J over Risperdal, Pharmalot, October 4, 2012
J&J aims to block ex-FDA chief's testimony in Risperdal case, Fierce Pharma, October 4, 2012
Ex-FDA chief David Kessler says J&J broke the law in promoting Risperdal, The Philadelphia Inquirer's "PhillyPharma" blog, October 4, 2012
Lawsuit: Risperdal Schizophrenia Drug Makes Boys Grow Breasts, Law.com blog, October 2, 2012
Products liability trial in Risperdal case opens, Pittsburgh Post-Gazette/The Legal Intelligencer, October 1, 2012
Psychiatrist, plaintiff's expert witness, testifies on third day of Philadelphia Risperdal trial, The Pennsylvania Record, Pennsylvania's Legal Journal, September 28, 2012
Mother asks judge to release J&J report, wants jurors to see, The Philadelphia Inquirer, September 28, 2012
'Risperdal Popcorn' - Part of Day 2 of Philly Trial, The Philadelphia Inquirer's "PhillyPharma" blog, September 26, 2012
Witness: J&J aimed Risperdal pitch at childrens' doctors, Fierce Pharma, September 26, 2012
Products liability trial in Risperdal case opens in Philadelphia, The Legal Intelligencer, September 25, 2012 (PDF of newspaper)
Janssen promoted Risperdal off label, jury hears, Law360/LexisNexis, September 25, 2012
J&J pushed Risperdal with golf, popcorn, witness says, Bloomberg News, September 25, 2012
Risperdal trial: Sales rep cites pressure from above, The Philadelphia Inquirer, September 25, 2012
J&J lawyers to jury: What Risperdal popcorn?, Pharmalot, September 25, 2012
Risperdal caused teen boy's breast growth, jury hears, Law360/LexisNexis, September 24, 2012
Chasing the press out of the room? A Q&A with Philadelphia Inquirer David Sell about his experience with J&J lawyers attempting to remove him from Risperdal trial jury selection, Pharmalot, September 21, 2012
Philly judge stops J&J attempt to bar Inquirer reporter, The Philadelphia Inquirer's "PhillyPharma" blog, September 21, 2012
Johnson & Johnson CEO will not have to testify in Risperdal drug case, The Philadelphia Inquirer & Bloomberg Business Week, September 21, 2012
J&J's Alex Gorsky testify? Much too busy . . . on the other side of the planet, The Philladelphia Inquirer's "PhillyPharma" blog, September 19, 2012
Lawyers seek to force J&J chief onto the stand in Risperdal case, Fierce Pharma, September 19, 2012
Risperdal mass tort case settles in Phila. on first day of trial, The Pennsylvania Record, Pennsylvania's Legal Journal, September 19, 2012
J&J's CEO Should Be Forced to Testify, Teen's Lawyers Say, Bloomberg, September 18, 2012
Lawyers in Risperdal case argue Johnson & Johnson's CEO should be called to testify, Asbury Park Press/NJ.com, September 18, 2012
Lawyers for Teen Boy Say J&J CEO Should Be Forced to Testify, Pharmalot, September 18, 2012
Attys Want J&J CEO to Testify in Risperdal Breast Growth Case, Law360/LexisNexis, September 18, 2012
J&J CEO Gorsky talks Risperdal, via deposition, with lawyers nearby, The Philladelphia Inquirer's "PhillyPharma" blog, September 19, 2012
J&J Settles Suit Over Risperdal and Male Breasts, PharmaLot.com, September 11, 2012
Johnson and Johnson settles Risperdal side effects lawsuit, The Philadelphia Inquirer, September 11, 2012
J&J settles Risperdal male breasts case on first day, Pharma Times Online, September 11, 2012
J&J Sees Male Breasts and Quickly Settles Risperdal Suit, Forbes, September 11, 2012
J&J Settles Risperdal Lawsuit on Opening Day of Trial, Bloomberg Business Week, September 10, 2012
Johnson & Johnson settles on first day of Philly Risperdal trial, The Philladelphia Inquirer & "PhillyPharma" blog, September 10, 2012
J&J Settles Lawsuit Alleging Injury from Antipsychotic, The Wall Street Journal/Dow Jones Newswire, September 10, 2012
J&J Settles PA Risperdal Lawsuit on Opening Day of Trial, Law 360/LexisNexis, September 10, 2012
J&J settles after plaintiff says drug caused him to grow breast tissue, Asbury Park Press, September 10, 2012
NEWS: Doctors Named in Novartis Kickback Case
NEWS: NFL & Players Have Their First Day in Court
IN THE NEWS: Sheller, P.C. Settlement Featured in The Legal Intelligencer "Top 10" since 1994
NEWS: Regulator Issues Fraud Alert on Doctor-Owned Distributors
NEWS: Massachusetts girl, parents awarded $63M in Motrin lawsuit
NEWS: Health Care Fraud Cases Yield $4.2 billion
NEWS: Shire agrees to settle ADHD drug inquiry
NEWS: Court says Pfizer can be sued by man who took generic drug
IN THE NEWS: Stephen Sheller profiled in Philadelphia Life Magazine
IN THE NEWS: Matthew Monroe interviews Hon. Pamela P. Dembe for "PA Justice News"
IN THE NEWS: Matthew Monroe quoted in PA Justice Verdict Magazine "Future Leaders" article
IN THE NEWS: Philadelphia Inquirer Calls McCormick's Appointment to City Ethics Board "Encouraging"
NEWS: Brian J. McCormick represents Temple Inn of Court in Washington, D.C.
IN THE NEWS: Sheller Risperdal settlements front page of The Legal Intelligencer
NEWS: Sheller attorneys investigate reports of Allergan Lap-Band injuries and deaths
NEWS: Sheller Client's Mother Asks Judge in Risperdal Trial to Release J&J Report for Jurors
SPEAKER: Attorney Jamie Sheller to present hip implant litigation strategies
IN THE NEWS: Sheller Products Liability Trial in Risperdal Case Opens in Phila.
NEWS: J&J Settles with Sheller, P.C. client on first day of Risperdal jury trial
IN THE NEWS: Sheller, P.C. profiled in Suburban Life magazine
NEWS: Stephen Sheller quoted by Pharma Gossip Blog on Off-Label Marketing of Drugs
NEWS: Sheller, P.C. Attorneys Honored Again in 2012 as SuperLawyers®
IN THE NEWS: Stephen A. Sheller and Brian J. McCormick Jr. on Insider Exclusive Documentaries
NEWS: Injured by Generic Drugs: Courts & Senators Rally for Patient Safety
LEGAL PUBLICATIONS NEWS: Sheller, P.C. #1 settlement in Pennsylvania, 2010
ON THE AIR, now online: Claudine Homolash discusses whistleblowers and more on radio
IN THE NEWS: Attorney Claudine Homolash Quoted by The Legal Intelligencer on PA Supreme Court Ruling
NEWS: J&J's Marketing of Risperdal Violated Law, Arkansas Jury Rules, $1.1B Penalty
NEWS: Generic Drugs Proving Resistant to Damage Suits
NEWS: Claudine Homolash Selected for 2012 "Women in the Profession" Roundtable
NEWS: Philadelphia Trial Lawyers Ask First Judicial District to Rethink Mass Torts Rules
NEWS: Monroe featured lecturer at CUNY School of Law on Whistleblower Law
NEWS: J&J to Pay $158M in Risperdal Case; Sheller Quoted on Mass Tort Litigation
NEWS: J&J Pushed Risperdal for Kids Without Approval, Memo Shows
NEWS: J&J Opposes Texas in $1 Billion Risperdal Marketing Trial
NEWS: J&J Said to Agree to $1B in Risperdal Marketing Probe
NEWS: Attorney Claudine Homolash selected for The Justinian Society
NEWS: Sheller, P.C. releases new video series, "What Is a Whistleblower Claim?"
IN THE NEWS: Attorney Jamie Sheller Quoted by Business Insurance on Data Breach Issues
NEWS: Sheller, P.C. Files Lawsuits Over Police 'Live Stop' Tactics
WHISTLEBLOWER WEBINAR: Attorneys Stephen Sheller and Claudine Homolash present LexisNexis program
NEWS: Sheller, P.C. Attorneys Recognized as 2011 SuperLawyers®
TEMPLE U. LAW SCHOOL ROSS MEMORIAL LECTURE: Stephen Sheller Presents Lecture
NEWS: Attorney Stephen Sheller Honored With First "Pioneer" Award at AAJ Conference
NEWS: McCormick on Trial Team for $1.8M Award
NEWS: Claudine Homolash named 2010 "Awesome Attorney" in Main Line Magazine
NEWS: Stephen Sheller quoted in New York Times article "Side Effects May Include Lawsuits"
IN THE COMMUNITY: Stephen Sheller throws first pitch at Philadelphia Phillies
NEWS: Jamie Sheller in Law.com and Legal Intelligencer on Paxil Birth Defects Cases
NEWS: Pennsylvania Higher Education Foundation Announces Sheller Scholarships
NEWS: Sheller, P.C. attorneys honored once again as SuperLawyers®, 2010
NEWS: Shellers Sponsor Pennsylvania National Guard Exhibit at the National Liberty Museum
NEWS: $520 Million Brings Total Sheller Pharma Whistleblower Settlements to $4.2 Billion
CONSUMER ALERT: Sheller, P.C. Attorneys investigating injuries from recalled Nissan vehicles
NEWS: Stephen Sheller quoted on front page of San Francisco Chronicle
NEWS: Stephen Sheller quoted in Legal Intelligencer story about Toyota litigation
NEWS: Sheller, P.C. Attorneys are featured faculty for Toyota Recall Litigation Conference
NEWS UPDATE Toyota Recall: Sheller, P.C. Filing National Class Action Against Toyota
NEWS: Stephen Sheller interviewed on WHYY about Whistleblower/False Claims Act cases
NEWS: New Paxil Birth Defects Cases
NEWS UPDATE: Sheller plans filing twenty to thirty more Risperdal/ Invega cases
NEWS: Sheller, P.C. Files Lawsuits Against Manufacturers of Antipsychotic Drugs Risperdal and Invega
CONSUMER ALERT: Recalled Flu Vaccine Prompts Sheller, P.C. Investigation
NEWS: Sheller, P.C. attorney Jamie Sheller appears on special broadcast of The American Law Journal
IN THE COMMUNITY: Shellers honored at National Philanthropy Day Awards
VERDICT: Jamie Sheller represents client in $2.5 million Paxil birth defects verdict
VERDICT: Sheller, P.C. Whistleblower Case: $2.3 Billion Settlement
VERDICT: Sheller, P.C. Whistleblower Case: $1.4 Billion Settlement
CONSUMER ALERT: Is there a link between antidepressants and Autism?
